R4	Coref Anaphora:T26 Antecedent:T7
R5	Coref Anaphora:T47 Antecedent:T49
T1	Protein 20 23	Fos
T2	Protein 29 32	Jun
T3	Protein 69 73	IL-2
T4	Protein 83 87	CD28
T5	Protein 138 142	CD28
T6	Protein 276 280	CD28
T7	Protein 301 305	IL-2
T8	Protein 419 423	CD28
T9	Protein 473 477	IL-2
T10	Protein 681 685	CD28
T11	Protein 802 806	CD28
T12	Protein 924 928	CD28
T13	Protein 1192 1196	IL-2
T14	Protein 1484 1489	c-Rel
T15	Protein 1518 1521	p50
T16	Protein 1526 1530	RelA
T17	Protein 1567 1572	c-Fos
T18	Protein 1577 1582	c-Jun
T19	Protein 1748 1752	IL-2
T20	Protein 1774 1778	CD28
T24	Exp 65 118	the IL-2 promoter CD28 response element/AP-1 sequence
T25	Exp 185 199	the activation
T26	Exp 318 323	which
T27	Exp 256 271	the Ag receptor
T28	Exp 336 351	the development
T29	Exp 415 435	the CD28 stimulation
T30	Exp 451 465	the activation
T31	Exp 469 486	the IL-2 promoter
T32	Exp 504 516	the activity
T33	Exp 756 760	that
T34	Exp 798 806	the CD28
T35	Exp 875 890	this conclusion
T36	Exp 915 919	that
T37	Exp 920 945	the CD28 response element
T38	Exp 1025 1046	the adjacent promoter
T39	Exp 1078 1093	this hypothesis
T40	Exp 1121 1138	the current study
T41	Exp 1160 1184	the CD28RE/AP-1 sequence
T42	Exp 1188 1205	the IL-2 promoter
T43	Exp 1344 1354	the CD28RE
T44	Exp 1359 1381	the adjacent AP-1 site
T45	Exp 1280 1293	this sequence
T46	Exp 1307 1322	these complexes
T47	Exp 1508 1512	that
T48	Exp 1386 1418	the NF-kappaB/Rel family members
T49	Exp 1499 1507	the fact
T50	Exp 1555 1565	the CD28RE
T51	Exp 1427 1443	this CD28RE/AP-1
T52	Exp 1601 1617	this CD28RE/AP-1
T53	Exp 1656 1660	that
T54	Exp 1700 1710	the CD28RE
T55	Exp 1715 1737	the AP-1-binding sites
T56	Exp 1636 1646	These data
